WHO Sets Up Panel To Review IPR Impact On Drugs

Law360, New York (February 20, 2004, 12:00 AM EST) -- The World Health Organization has set up a commission to review how intellectual property rights affect the creation of new drugs against “diseases of poverty” in the developing world.

The commission, set up at the request of last year's World Health Assembly, will review existing research, development and innovation efforts directed at diseases that affect the poor.

Its report will consider how effectively intellectual property regimes and other incentive and funding mechanisms are stimulating research into new medicines against these diseases.

Governments, United Nations agencies, private-sector...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.